Anzeige
Mehr »
Dienstag, 30.09.2025 - Börsentäglich über 12.000 News
Das Geheimnis der Wall Street: Diese Kupferaktie wird bewertet wie ein Nobody - hat aber das Zeug zum Giganten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 856532 | ISIN: JP3902400005 | Ticker-Symbol: MIE1
Tradegate
30.09.25 | 09:58
21,690 Euro
+0,60 % +0,130
1-Jahres-Chart
MITSUBISHI ELECTRIC CORPORATION Chart 1 Jahr
5-Tage-Chart
MITSUBISHI ELECTRIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
21,63022,05017:50
21,68022,01017:50
ACCESS Newswire
221 Leser
Artikel bewerten:
(1)

MassRobotics Opens Applications for Healthcare Robotics Catalyst Program, Cohort 5, Presented by Festo, Mitsubishi Electric Automation, Novanta, and MITRE

Non-equity program pairs early and growth-stage startups with industry mentors, applications due Dec 1, 2025

BOSTON, MA / ACCESS Newswire / September 30, 2025 / MassRobotics announced the call for applicants for Cohort 5 of its Healthcare Robotics Startup Catalyst Program, a five-month, non-equity initiative that helps robotics and automation teams accelerate clinical readiness, technical validation, and go-to-market in healthcare and life sciences. Applications open today and close on December 1, 2025. The cohort will run January through May 2026, concluding with company showcases at the Robotics Summit and Expo in Boston.

MassRobotics is expanding its Medical Advisory Board for Cohort 5 with additional advisors from Mass General Brigham and others, adding depth in perioperative care, patient safety, and clinical workflow integration. The expanded board brings system-level innovation expertise and perioperative insight to help founders design viable pilots and clinical evidence plans.

The Catalyst Program connects selected startups with senior mentors from Festo, Novanta, Mitsubishi Electric Automation, MITRE, and yaxxoo, along with practicing clinicians and leading organizations in the medical field. Companies work toward practical milestones such as proof-of-concept builds, pilot design, regulatory planning, or systems integration, supported by organizational/technical support and biweekly mentor cadence.

"Having supported the MassRobotics Healthcare Catalyst Program for three years, I'm proud of the journey we at Festo have taken-from founding member to seeing standout startups like Tenomix thrive. I'm excited to continue empowering startups to scale with Cohort 5 and shape the future of healthcare robotics." Johannes Linzbach, Head of Research Hub Boston, Festo.

"The Catalyst Program has been a truly pivotal part of our journey. When you're building a first-in-class AI-enabled robotic platform in healthcare, you need creative thinking, honest feedback, and a community that pushes you forward. MassRobotics delivered exactly that. From mentors who guided us on everything from refining technical components to exploring innovative pricing models like Robotics-as-a-Service, to a network of clinicians, engineers, and investors who became long-term collaborators, we gained the insights and support we needed to make the right decisions at the right time. Those decisions led us to successfully demo our pre-commercial robot at the Robotics Summit and Expo, where the response was incredible. Beyond the program, the Boston community around MassRobotics is something special. We've built lifelong connections that are already helping us in our current investment round. If you're working on healthcare robotics, I can't recommend this program enough: you have to apply." Saumik Biswas, CEO of Tenomix (Cohort 4).

Who should apply

Startups building robotics or automation for healthcare and biotech, including but not limited to: lab and pharma automation, diagnostics and imaging workflows, hospital logistics, rehabilitation and assistive devices, surgical and interventional robotics, and enabling technologies such as sensing, precision motion, and cybersecurity for medical devices. The program is open to global teams. Both earlier teams and more mature companies, including those at Seed through Series C, are encouraged to apply.

What participants receive

  • Tailored mentorship with senior experts from Festo, Mitsubishi Electric Automation, Novanta, MITRE, and yaxxoo

  • Clinical perspective through the Medical Advisory Board

  • Structured onboarding, goal setting, and biweekly mentor working sessions

  • Custom workshops based on cohort needs on regulatory strategy, cybersecurity and SBOMs, clinical workflow, pilot design and more!

  • Visibility through MassRobotics channels and the Robotics Summit showcase in May

Selection criteria

Applicants are evaluated on technical maturity, clinical relevance, feasibility of near-term milestones, program fit, and mentor alignment. Teams able to pursue a proof-of-concept during the five-month program are especially encouraged to apply.

Key dates

  • Applications open: September 30, 2025 - December 1, 2025

  • Evaluation and interviews: December 1 to December 15, 2025

  • Cohort announcement: January 5, 2026

  • Program period: January to May 2026

How to apply

Complete the short application here. Questions can be directed to info@massrobotics.org.

About MassRobotics:

MassRobotics is the world's largest independent robotics hub dedicated to accelerating robotics innovation, commercialization and adoption.

Our mission is to help create and scale the next generation of successful robotics and Physical AI technology companies by providing entrepreneurs and startups with the workspace, resources, programming and connections they need to develop, prototype, test and commercialize their products and solutions. While MassRobotics originated and is headquartered in Boston, we are reaching and supporting robotics acceleration and adoption globally and are working with startups, academia, industry and governments both domestically and internationally. Learn more about MassRobotics here

Media Contact

Sayo Tirrell
sayo@massrobotics.org

SOURCE: MassRobotics



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/massrobotics-opens-applications-for-healthcare-robotics-catalyst-1079542

© 2025 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.